BG101325A - Use of muramyl peptide compounds - Google Patents
Use of muramyl peptide compoundsInfo
- Publication number
- BG101325A BG101325A BG101325A BG10132597A BG101325A BG 101325 A BG101325 A BG 101325A BG 101325 A BG101325 A BG 101325A BG 10132597 A BG10132597 A BG 10132597A BG 101325 A BG101325 A BG 101325A
- Authority
- BG
- Bulgaria
- Prior art keywords
- treatment
- peptide compounds
- muramyl
- muramyl peptide
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Certain muramul peptide derivatives such as GMDP findparticular use in the treatment of ophthalmic conditions such asherpetic keratitis and herpetic keratouveitis. The muramyl peptidederivatives are particularly useful for reducing or preventingcorneal scarring which may occur as a result of conditions such askeratitis. Treatment with muramyl peptide compounds may be used inaddition to treatment with other drugs.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9419011A GB9419011D0 (en) | 1994-09-21 | 1994-09-21 | Use of muramyl peptide compounds |
| PCT/GB1995/002237 WO1996009063A1 (en) | 1994-09-21 | 1995-09-20 | Use of muramyl peptide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG101325A true BG101325A (en) | 1998-01-30 |
Family
ID=10761674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101325A BG101325A (en) | 1994-09-21 | 1997-03-13 | Use of muramyl peptide compounds |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0782454A1 (en) |
| JP (1) | JPH10506387A (en) |
| KR (1) | KR970706015A (en) |
| AU (1) | AU3527495A (en) |
| BG (1) | BG101325A (en) |
| CA (1) | CA2200570A1 (en) |
| CZ (1) | CZ86197A3 (en) |
| GB (1) | GB9419011D0 (en) |
| HU (1) | HUT77741A (en) |
| IL (1) | IL115391A0 (en) |
| SK (1) | SK36697A3 (en) |
| WO (1) | WO1996009063A1 (en) |
| ZA (1) | ZA957997B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6693396A (en) * | 1995-08-08 | 1997-03-05 | Allergan, Inc. | Method of increasing tear production by topical administration of muramyl peptide |
| DE10106852A1 (en) * | 2001-02-14 | 2002-09-05 | T Luger | Anti-inflammatory compounds |
| CN108785251B (en) * | 2018-01-23 | 2020-11-24 | 盛元医药广州有限公司 | Medicinal composition for eyes and preparation method and application thereof |
| BR112023018950A2 (en) | 2021-03-19 | 2024-02-27 | Icahn School Med Mount Sinai | COMPOUND, NANOBIOLOGICAL AND PHARMACEUTICAL COMPOSITIONS, METHODS FOR TREATING A CELL PROLIFERATION DISORDER, FOR TREATING SEPSIS AND FOR ACTIVATING A NOD2 RECEPTOR, PROCESS FOR MANUFACTURING A NANOBIOLOGICAL COMPOSITION AND KIT |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0026746B1 (en) * | 1979-10-02 | 1985-04-10 | Ciba-Geigy Ag | Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production |
| EP0056560A1 (en) * | 1981-01-19 | 1982-07-28 | Ciba-Geigy Ag | Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics |
| EP0102319B1 (en) * | 1982-07-23 | 1987-08-19 | Ciba-Geigy Ag | Prophylactic and therapeutic use of muramyl peptides and their analogues against viral infections |
| AU6066390A (en) * | 1989-07-19 | 1991-02-22 | Upjohn Company, The | Peptides containing diamino-glycols as transition-state mimics |
| WO1993010148A1 (en) * | 1991-11-19 | 1993-05-27 | Peptech (Uk) Limited | Muramyl compounds for treatment of septic shock |
| US5679348A (en) * | 1992-02-03 | 1997-10-21 | Cedars-Sinai Medical Center | Immunotherapy for recurrent HSV infections |
| MX9301789A (en) * | 1992-04-03 | 1993-10-01 | Iaf Biochem Int | NEW LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY. |
-
1994
- 1994-09-21 GB GB9419011A patent/GB9419011D0/en active Pending
-
1995
- 1995-09-20 AU AU35274/95A patent/AU3527495A/en not_active Abandoned
- 1995-09-20 JP JP8510688A patent/JPH10506387A/en active Pending
- 1995-09-20 CZ CZ97861A patent/CZ86197A3/en unknown
- 1995-09-20 KR KR1019970701823A patent/KR970706015A/en not_active Application Discontinuation
- 1995-09-20 WO PCT/GB1995/002237 patent/WO1996009063A1/en not_active Application Discontinuation
- 1995-09-20 CA CA002200570A patent/CA2200570A1/en not_active Abandoned
- 1995-09-20 SK SK366-97A patent/SK36697A3/en unknown
- 1995-09-20 EP EP95932084A patent/EP0782454A1/en not_active Withdrawn
- 1995-09-20 HU HU9800756A patent/HUT77741A/en unknown
- 1995-09-21 ZA ZA957997A patent/ZA957997B/en unknown
- 1995-09-21 IL IL11539195A patent/IL115391A0/en unknown
-
1997
- 1997-03-13 BG BG101325A patent/BG101325A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3527495A (en) | 1996-04-09 |
| IL115391A0 (en) | 1995-12-31 |
| WO1996009063A1 (en) | 1996-03-28 |
| GB9419011D0 (en) | 1994-11-09 |
| CZ86197A3 (en) | 1997-08-13 |
| CA2200570A1 (en) | 1996-03-28 |
| ZA957997B (en) | 1997-03-24 |
| EP0782454A1 (en) | 1997-07-09 |
| SK36697A3 (en) | 1997-11-05 |
| HUT77741A (en) | 1998-07-28 |
| JPH10506387A (en) | 1998-06-23 |
| KR970706015A (en) | 1997-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
| LU90856I2 (en) | Uprima - apomorphine hydrochloride and its pharmaceutically acceptable derivatives | |
| BG100974A (en) | Vaccines against papillomavirus | |
| ATE280826T1 (en) | CC CHEMOKINCEPTOR C-C CKR-5, DERIVATIVES THEREOF AND USES | |
| AU2305295A (en) | Use of serotonin antagonists (5HT3) for treating fibro myalgia | |
| GB9907461D0 (en) | Neurite regeneration | |
| PL319833A1 (en) | Compounds and composition for carrying active media | |
| BG95935A (en) | METHOD AND AGENT FOR ADMINISTERING DEXMEDETOMIDINE DIRECTLY THROUGH THE SKIN | |
| GR3023233T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| AU3380797A (en) | Hypodermic injector system and method for maintaining the sterility thereof prior to use | |
| UA41355C2 (en) | Agent for treating neuro-aids | |
| AU5727296A (en) | 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents | |
| ES2134801T3 (en) | CRYSTAL TIAGABINE HYDROCHLORIDE MONOHYDRATE, ITS PREPARATION AND USE. | |
| BR0009524A (en) | Use of a compound, and, pharmaceutical or veterinary composition | |
| CA2254682A1 (en) | Method of treating eye infections with azithromycin | |
| DE69311541D1 (en) | COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING THE DEACYLATED GLYCEROPHOSPHOLIPIDES | |
| SE9402880D0 (en) | New peptide derivatives | |
| AU3717995A (en) | Mutant activated gsalpha* and adenylyl cyclase 2 for use as therapeutic agents | |
| BG101325A (en) | Use of muramyl peptide compounds | |
| MX9707875A (en) | Levobupivacaine and its use as an anaesthetic in pregnant women. | |
| GB2324091A (en) | Metalloproteinase inhibitors | |
| HU9700661D0 (en) | Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer | |
| EP0971725A4 (en) | Methods for treatment of scar tissue | |
| AU3600199A (en) | A pharmaceutical composition containing ezrin mutated on tyrosine 353 | |
| AU7439996A (en) | Novel uses of mammalian ctla-8 and related reagents |